NAD(P)H:quinone reductase activity in human epidermal keratinocytes and reconstructed epidermal models

Skin Pharmacology and Applied Skin Physiology

Volumn 15, Issue SUPPL. 1, 2002, Pages 68-73

  Harris, Ian R ^a   Siefken, Wilfried ^a   Beck Oldach, Konstanze ^a   Wittern, Klaus Peter ^a   Pollet, Dieter ^a  

^a BEIERSDORF AG   (Germany)

Author keywords

Detoxification; Keratinocyte; Quinone reductase; Reconstructed skin; Skin; Xenobiotics

Indexed keywords

DICOUMAROL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; BIOLOGICAL MODEL; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; ARTIFICIAL SKIN; COMPARATIVE STUDY; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ENZYME ACTIVATION; EPIDERMIS; HUMANS; KERATINOCYTES; NAD(P)H DEHYDROGENASE (QUINONE); NADP; SKIN, ARTIFICIAL;

EID: 0036460603     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066677     Document Type: Article

References (11)

1. Smith MT: Quinones as mutagens, carcinogens, and anticancer agents: Introduction and overview. J Toxicol Environ Health 1985;16:665-672.
2. Pryor WA, Hales BJ, Premovic PI, Church DF: The radicals in cigarette tar: Their nature and suggested physiological implications. Science 1982;220:425-427.
3. Scheutzle DL: Sampling of vehicle emissions for chemical analysis and biological testing. Environ Health Perspect 1983;47:65-80.
4. Bianchet MA, Foster C, Faig M, Talalay P, Amzel LM: Structure and mechanism of cytosolic quinone reductases. Biochem Soc Transact 1999;27:610-615.
5. Rauth AM, Goldberg Z, Misra V: DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis. Oncol Res 1997;9:339-349.
6. Schulz WA, Krummeck A, Roesinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Draeger BJ, Sies H: Increased frequency of a nullallele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997;7:235-239.
7. Merk H, Bonnekoh B, Mahrle G: Induction and inhibition of NAD(P)H:quinone reductase in murine skin and human skin. Skin Pharmacol 1991;4:183-190.
8. Merk HF, Jugert FK: Cutaneous NAD(P)H:quinone reductase: A xenobiotica-metabolizing enzyme with potential cancer and oxidation stress-protecting properties. Skin Pharmacol 1991;4:95-100.
9. Prochaska HJ, Santamaria AB: Direct measurement of NAD(P):quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers. Anal Biochem 1988;169:328-336.
10. Boelsma E, Gibbs S, Faller C, Ponec M: Characterization and comparison of reconstructed skin models: Morphological and immunohistochemical evaluation. Acta Derm Venereol 2000;80:89-93.
11. Ponec M, Boelsma E, Weerheim A, Mulder A, Bouwstra J, Mommaas M: Lipid and ultrastructural characterization of reconstructed skin models. Int J Pharm 2000;203:211-225.